DOI: 10.1055/s-00032260

Digestive Disease Interventions

References

Rinke A, Wittenberg M, Schade-Brittinger C. PROMID Study Group. et al.
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors (PROMID): results of long-term survival.

Neuroendocrinology 2017;
104 (01) 26-32

Download Bibliographical Data

Access:
Access: